Benzinga | Nov 22, 2021 11:58AM EST

HC Wainwright & Co. Maintains Buy on Chimerix, Raises Price Target to $21

HC Wainwright & Co. analyst Edward White maintains Chimerix (NASDAQ:CMRX) with a Buy and raises the price target from $19 to $21.